A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells
======================================================================================================================================================================

* Junko Matsuzaki
* Takemasa Tsuji
* Thinle Chodon
* Courtney Ryan
* Richard C. Koya
* Kunle Odunsi